Polaris Group
TWSE:6550

Watchlist Manager
Polaris Group Logo
Polaris Group
TWSE:6550
Watchlist
Price: 52.4 TWD -0.38% Market Closed
Market Cap: 39.1B TWD
Have any thoughts about
Polaris Group?
Write Note

Polaris Group
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Polaris Group
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Polaris Group
TWSE:6550
Cash Equivalents
NT$1.8B
CAGR 3-Years
N/A
CAGR 5-Years
272%
CAGR 10-Years
N/A
Beigene Ltd
SSE:688235
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Tanvex BioPharma Inc
TWSE:6541
Cash Equivalents
NT$155.6m
CAGR 3-Years
N/A
CAGR 5-Years
-37%
CAGR 10-Years
N/A
No Stocks Found

Polaris Group
Glance View

Market Cap
39B TWD
Industry
Biotechnology

Polaris Group engages in the research and development of biotechnology drugs. The firm provides senior care and long-term care with clinical, operational and financial solutions to meet the challenges presented by the long-term-care industry. The firm provides healthcare consulting and staffing solutions. Its healthcare consulting services include Medicare consulting, clinical compliance, mock surveys, analytics, revenue cycle management and additional services. Its staffing solutions include interim staffing, permanent staffing, outsourced MDS coordinators and find a job. The company provides services in ALL 50 states and have a regulatory division to interpret and educate its staff on the state and federal regulations.

Intrinsic Value
3.1 TWD
Overvaluation 94%
Intrinsic Value
Price

See Also

What is Polaris Group's Cash Equivalents?
Cash Equivalents
1.8B TWD

Based on the financial report for Dec 31, 2023, Polaris Group's Cash Equivalents amounts to 1.8B TWD.

What is Polaris Group's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
272%

Over the last year, the Cash Equivalents growth was -73%.

Back to Top